Facts about male breast cancer (Prostrate cancer)
Akron Beacon Journal, OH - Oct 26, 2006AP. _ Male breast cancer is rare with fewer than 1 percent of all breast cancer cases occurring in men. _ Incidence rates for men ...
MedPage Today, NJ - 22 hours agoLAS VEGAS, Oct. 27 -- A glass of red wine per day may fend off colorectal neoplasia or colon cancer, researchers here suggested. ...
Today's Sunbeam, NJ - 12 hours agoCARNEYS POINT TWP. -- As a 20-year breast cancer survivor, Diana Oliver decided to do something to raise awareness of the disease in Salem County. ...
MedIndia, India - 8 hours ago... Natasha Blakeney Wilson, a minority outreach coordinator at the UM Comprehensive Cancer Center and the Body & Soul program said "As the church's spiritual and ...
Nanotechwire.com, PA - 6 hours agoOne of the more difficult diagnostic tasks an oncologist faces is determining if cancer has spread to the lymphatic system, particularly when it is necessary ...
Cancerpage.com, GA - Oct 27, 2006NEW YORK OCT 27, 2006 (Reuters Health) - While androgen deprivation using GnRH agonists is a mainstay of treatment for advanced prostate cancer, new research ...
MedPage Today, NJ - 22 hours agoLAS VEGAS, Oct. 27 -- A glass of red wine per day may fend off colorectal neoplasia or colon cancer, researchers here suggested. ...
Today's Sunbeam, NJ - 12 hours agoCARNEYS POINT TWP. -- As a 20-year breast cancer survivor, Diana Oliver decided to do something to raise awareness of the disease in Salem County. ...
MedIndia, India - 8 hours ago... Natasha Blakeney Wilson, a minority outreach coordinator at the UM Comprehensive Cancer Center and the Body & Soul program said "As the church's spiritual and ...
Nanotechwire.com, PA - 6 hours agoOne of the more difficult diagnostic tasks an oncologist faces is determining if cancer has spread to the lymphatic system, particularly when it is necessary ...
Cancerpage.com, GA - Oct 27, 2006NEW YORK OCT 27, 2006 (Reuters Health) - While androgen deprivation using GnRH agonists is a mainstay of treatment for advanced prostate cancer, new research ...









